Key Highlights

  • Inovio Pharmaceuticals (NASDAQ:INO) was up 195.48 percent to USD 1.78 after an FDA accelerated approval.
  • ClearOne (NASDAQ:CLRO) was up 78.01 percent to USD 6.07 with its Cortigent Merger still pending.
  • INLIF (NASDAQ:INLF) was up 47.73 percent to USD 0.2733, with no announcement identified.
  • 22nd Century Group (NASDAQ:XXII) was up 32.90 percent to USD 0.0925 after a Gopuff delivery agreement.
  • Perion Network (NASDAQ:PERI) was up 30.46 percent to USD 11.35 on an all-cash merger agreement.

Inovio Pharmaceuticals (NASDAQ:INO): An FDA Accelerated Approval Drives a Near Tripling

Inovio Pharmaceuticals (NASDAQ:INO) was up 195.48 percent to USD 1.78 in pre-market trading on November 2, 2026. The move follows a company announcement dated October 30, 2026, that the US Food and Drug Administration granted accelerated approval to VOCERYQ for adults with recurrent respiratory papillomatosis.

In the efficacy population, 7 of 26 patients, or 27 percent, had no surgical papilloma removal over 12 months. The company expects shipping in about 60 days. Cash was USD 36.7 million at June 30, 2026, excluding USD 18.3 million of net July offering proceeds. Penny stocks can be volatile and thinly traded, and a short runway raises the prospect of further dilution.

ClearOne (NASDAQ:CLRO): A Large Jump With a Merger Still Awaiting Approval

ClearOne (NASDAQ:CLRO) was up 78.01 percent to USD 6.07 in pre-market trading on November 2, 2026. No company announcement dated November 2, 2026 was identified, and the latest relevant item is a statement published on October 30, 2026 that the Cortigent merger remained pending final regulatory approval.

Under the agreement, Vivani Medical would hold about 77.98 percent of the combined company, and closing depends on a financing of USD 10.0 million to USD 15.0 million. Cortigent is pre-revenue, so the structure carries dilution, approval and delay risk.

INLIF (NASDAQ:INLF): A Sub-Dollar Rally Without an Identified Catalyst

INLIF (NASDAQ:INLF) was up 47.73 percent to USD 0.2733 in pre-market trading on November 2, 2026. No company announcement dated November 2, 2026 was identified, and the latest release was the October 20, 2026 closing of a USD 3.75 million registered direct offering. The move may reflect low float momentum, which is a measured inference and not a confirmed cause.

The Chinese industrial machinery producer reported first half 2026 Revenue of USD 12.94 million, up 26.01 percent, and cash of USD 45.47 million at June 30, 2026. It also carried out two share combinations this year. As a penny stock, INLIF can be volatile, thinly traded and prone to sharp reversals, and warrants with reset features point to continued dilution.

22nd Century Group (NASDAQ:XXII): A Penny Stock Rebound After Late October News

22nd Century Group (NASDAQ:XXII) was up 32.90 percent to USD 0.0925 in pre-market trading on November 2, 2026. No company announcement dated November 2, 2026 was identified, so the move may be a bounce or momentum trade, which is an inference and not a confirmed cause.

On October 29, 2026, the company said it signed a trade agreement to offer its Pinnacle products through the Gopuff delivery app, with a launch expected in late fourth quarter 2026. Preliminary third quarter revenue was about USD 4.8 million, with a net loss of USD 2.6 million, though the figures are unaudited and subject to change. Quarter end cash of USD 3.9 million is small against that loss, which raises the chance of further financing and dilution.

Perion Network (NASDAQ:PERI): Trading Just Under a USD 11.70 Cash Offer

Perion Network (NASDAQ:PERI) was up 30.46 percent to USD 11.35 in pre-market trading on November 2, 2026. The move followed a press release dated November 1, 2026 announcing a definitive merger agreement with Affle at USD 11.70 per share in cash. The company said this is a 34.5 percent premium to the October 30, 2026 close and values the Equity at about USD 420 million.

The pre-market price sits about 2.99 percent below the offer (calculated), a gap that usually reflects timing and completion risk. Closing is expected in early 2027, subject to Shareholder approval and Hart-Scott-Rodino clearance. A go-shop period runs until December 11, 2026, and the company said there is no assurance it will produce a superior offer.

Where Things Stand

The five stocks reached the top of the pre-market list for different reasons. Inovio and Perion have clear company announcements behind them, ClearOne has a pending merger, and INLIF and 22nd Century Group moved without a new announcement identified for November 2, 2026. Three of the five trade below USD 5 and are best viewed as penny stocks, where thin Liquidity can amplify moves in either direction. Items to watch include Inovio shipments, any regulatory clearance for ClearOne, the 22nd Century Group third quarter report and the Perion go-shop deadline.